Developing countries need drugs at affordable cost for prevention of AIDS
Identifieur interne : 001091 ( Main/Exploration ); précédent : 001090; suivant : 001092Developing countries need drugs at affordable cost for prevention of AIDS
Auteurs : Anand Kumar [Inde]Source :
- Reproductive BioMedicine Online [ 1472-6483 ] ; 2001.
Descripteurs français
- Wicri :
- topic : Action en justice.
English descriptors
- KwdEn :
- Abbas road, Adequate steps, Affordable, Affordable cost, Affordable prices, Africa aids conference, Africa aids fight, Africa fight aids, African countries, African government, African health minister, African judge edwin cameron, Aids anand kumar, Aids apathy, Aids crisis, Aids drugs, Anand kumar hope infertility clinic, Asian wall street journal, Associate professor, Average time, Bombay university, Capita expenditure, Catastrophic situation, Causative agent, Cheap drugs, Cheaper versions, Civilized societies, Clinical trials, Commercial opportunity, Companies charge, Competitive prices, Compulsory licensing, Costly treatment, Countries india, Countries need, Countries need drugs, Court action, Current approach, Current price, Demographic characteristics, Drug companies, Drug companies sound, Drugs patent, Durban, Durban conference, Durban meeting, Dynamic leadership, Epidemiological proportions, Exclusive basis, Expensive drugs, Free importation, Gatt, Gatt treaty, General agreement, Generic drugs, Generic forms, Generic sources, Glaxo smith kline, Global attention, Global scale, Good intentions, Heavy investments, High cost, High quality, Hope infertiltiy clinic, Human disease, Human immunodeficiency virus, Humane response, Icmr institute, India institute, Intellectual property laws, Intellectual property rights, Journal middle, Kumar agreement, Lancet, Legal action, Legal method, Legitimate steps, Long time, Lower birth rates, Manufacturers association, Manufacturing capabilities, Many books, Medical problem, Medical sciences, Moral pressure, More leeway, National institutes, News item, News items, Nonexclusive basis, Nucleoside analogue, Older people, Patent infringement, Patent laws, Patent protection, Pharmaceutical, Pharmaceutical aids, Pharmaceutical companies, Policy change, Poor countries, Poor people, Poorer nations, Preventable deaths, Price controls, Price variations, Protease inhibitors, Public hospitals, Public laboratories, Public research institutes, Public research institutions, Rajasthan university, Recent price comparison, Recent report, References asian wall street journal, Reproductive biology, Reproductive biomedicine, Reproductive endocrinology, Retrospective commentaries, Rich country, Similar manufacturing capabilities, Societal disruption, Stark warning, Such arguments, Such inequities, Supply drugs, Third world, Triple therapy, Unblocks drugs, World health organization, World news service, World service, World service report, World trade organisation, Younger adults.
- Teeft :
- Abbas road, Adequate steps, Affordable, Affordable cost, Affordable prices, Africa aids conference, Africa aids fight, Africa fight aids, African countries, African government, African health minister, African judge edwin cameron, Aids anand kumar, Aids apathy, Aids crisis, Aids drugs, Anand kumar hope infertility clinic, Asian wall street journal, Associate professor, Average time, Bombay university, Capita expenditure, Catastrophic situation, Causative agent, Cheap drugs, Cheaper versions, Civilized societies, Clinical trials, Commercial opportunity, Companies charge, Competitive prices, Compulsory licensing, Costly treatment, Countries india, Countries need, Countries need drugs, Court action, Current approach, Current price, Demographic characteristics, Drug companies, Drug companies sound, Drugs patent, Durban, Durban conference, Durban meeting, Dynamic leadership, Epidemiological proportions, Exclusive basis, Expensive drugs, Free importation, Gatt, Gatt treaty, General agreement, Generic drugs, Generic forms, Generic sources, Glaxo smith kline, Global attention, Global scale, Good intentions, Heavy investments, High cost, High quality, Hope infertiltiy clinic, Human disease, Human immunodeficiency virus, Humane response, Icmr institute, India institute, Intellectual property laws, Intellectual property rights, Journal middle, Kumar agreement, Lancet, Legal action, Legal method, Legitimate steps, Long time, Lower birth rates, Manufacturers association, Manufacturing capabilities, Many books, Medical problem, Medical sciences, Moral pressure, More leeway, National institutes, News item, News items, Nonexclusive basis, Nucleoside analogue, Older people, Patent infringement, Patent laws, Patent protection, Pharmaceutical, Pharmaceutical aids, Pharmaceutical companies, Policy change, Poor countries, Poor people, Poorer nations, Preventable deaths, Price controls, Price variations, Protease inhibitors, Public hospitals, Public laboratories, Public research institutes, Public research institutions, Rajasthan university, Recent price comparison, Recent report, References asian wall street journal, Reproductive biology, Reproductive biomedicine, Reproductive endocrinology, Retrospective commentaries, Rich country, Similar manufacturing capabilities, Societal disruption, Stark warning, Such arguments, Such inequities, Supply drugs, Third world, Triple therapy, Unblocks drugs, World health organization, World news service, World service, World service report, World trade organisation, Younger adults.
Url:
DOI: 10.1016/S1472-6483(10)62178-5
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000525
- to stream Istex, to step Curation: 000525
- to stream Istex, to step Checkpoint: 000625
- to stream Main, to step Merge: 001163
- to stream Main, to step Curation: 001091
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Developing countries need drugs at affordable cost for prevention of AIDS</title>
<author><name sortKey="Kumar, Anand" sort="Kumar, Anand" uniqKey="Kumar A" first="Anand" last="Kumar">Anand Kumar</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:42F16BF47161A6DDF7518785277F45A90B716F0F</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S1472-6483(10)62178-5</idno>
<idno type="url">https://api.istex.fr/document/42F16BF47161A6DDF7518785277F45A90B716F0F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000525</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000525</idno>
<idno type="wicri:Area/Istex/Curation">000525</idno>
<idno type="wicri:Area/Istex/Checkpoint">000625</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000625</idno>
<idno type="wicri:doubleKey">1472-6483:2001:Kumar A:developing:countries:need</idno>
<idno type="wicri:Area/Main/Merge">001163</idno>
<idno type="wicri:Area/Main/Curation">001091</idno>
<idno type="wicri:Area/Main/Exploration">001091</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Developing countries need drugs at affordable cost for prevention of AIDS</title>
<author><name sortKey="Kumar, Anand" sort="Kumar, Anand" uniqKey="Kumar A" first="Anand" last="Kumar">Anand Kumar</name>
<affiliation wicri:level="1"><country xml:lang="fr">Inde</country>
<wicri:regionArea>Hope Infertility Clinic, 12 Aga Abbas Road, Bangalore 560 042</wicri:regionArea>
<wicri:noRegion>Bangalore 560 042</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Reproductive BioMedicine Online</title>
<title level="j" type="abbrev">RBMO</title>
<idno type="ISSN">1472-6483</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">2</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="3">3</biblScope>
<biblScope unit="page" to="4">4</biblScope>
</imprint>
<idno type="ISSN">1472-6483</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1472-6483</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abbas road</term>
<term>Adequate steps</term>
<term>Affordable</term>
<term>Affordable cost</term>
<term>Affordable prices</term>
<term>Africa aids conference</term>
<term>Africa aids fight</term>
<term>Africa fight aids</term>
<term>African countries</term>
<term>African government</term>
<term>African health minister</term>
<term>African judge edwin cameron</term>
<term>Aids anand kumar</term>
<term>Aids apathy</term>
<term>Aids crisis</term>
<term>Aids drugs</term>
<term>Anand kumar hope infertility clinic</term>
<term>Asian wall street journal</term>
<term>Associate professor</term>
<term>Average time</term>
<term>Bombay university</term>
<term>Capita expenditure</term>
<term>Catastrophic situation</term>
<term>Causative agent</term>
<term>Cheap drugs</term>
<term>Cheaper versions</term>
<term>Civilized societies</term>
<term>Clinical trials</term>
<term>Commercial opportunity</term>
<term>Companies charge</term>
<term>Competitive prices</term>
<term>Compulsory licensing</term>
<term>Costly treatment</term>
<term>Countries india</term>
<term>Countries need</term>
<term>Countries need drugs</term>
<term>Court action</term>
<term>Current approach</term>
<term>Current price</term>
<term>Demographic characteristics</term>
<term>Drug companies</term>
<term>Drug companies sound</term>
<term>Drugs patent</term>
<term>Durban</term>
<term>Durban conference</term>
<term>Durban meeting</term>
<term>Dynamic leadership</term>
<term>Epidemiological proportions</term>
<term>Exclusive basis</term>
<term>Expensive drugs</term>
<term>Free importation</term>
<term>Gatt</term>
<term>Gatt treaty</term>
<term>General agreement</term>
<term>Generic drugs</term>
<term>Generic forms</term>
<term>Generic sources</term>
<term>Glaxo smith kline</term>
<term>Global attention</term>
<term>Global scale</term>
<term>Good intentions</term>
<term>Heavy investments</term>
<term>High cost</term>
<term>High quality</term>
<term>Hope infertiltiy clinic</term>
<term>Human disease</term>
<term>Human immunodeficiency virus</term>
<term>Humane response</term>
<term>Icmr institute</term>
<term>India institute</term>
<term>Intellectual property laws</term>
<term>Intellectual property rights</term>
<term>Journal middle</term>
<term>Kumar agreement</term>
<term>Lancet</term>
<term>Legal action</term>
<term>Legal method</term>
<term>Legitimate steps</term>
<term>Long time</term>
<term>Lower birth rates</term>
<term>Manufacturers association</term>
<term>Manufacturing capabilities</term>
<term>Many books</term>
<term>Medical problem</term>
<term>Medical sciences</term>
<term>Moral pressure</term>
<term>More leeway</term>
<term>National institutes</term>
<term>News item</term>
<term>News items</term>
<term>Nonexclusive basis</term>
<term>Nucleoside analogue</term>
<term>Older people</term>
<term>Patent infringement</term>
<term>Patent laws</term>
<term>Patent protection</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical aids</term>
<term>Pharmaceutical companies</term>
<term>Policy change</term>
<term>Poor countries</term>
<term>Poor people</term>
<term>Poorer nations</term>
<term>Preventable deaths</term>
<term>Price controls</term>
<term>Price variations</term>
<term>Protease inhibitors</term>
<term>Public hospitals</term>
<term>Public laboratories</term>
<term>Public research institutes</term>
<term>Public research institutions</term>
<term>Rajasthan university</term>
<term>Recent price comparison</term>
<term>Recent report</term>
<term>References asian wall street journal</term>
<term>Reproductive biology</term>
<term>Reproductive biomedicine</term>
<term>Reproductive endocrinology</term>
<term>Retrospective commentaries</term>
<term>Rich country</term>
<term>Similar manufacturing capabilities</term>
<term>Societal disruption</term>
<term>Stark warning</term>
<term>Such arguments</term>
<term>Such inequities</term>
<term>Supply drugs</term>
<term>Third world</term>
<term>Triple therapy</term>
<term>Unblocks drugs</term>
<term>World health organization</term>
<term>World news service</term>
<term>World service</term>
<term>World service report</term>
<term>World trade organisation</term>
<term>Younger adults</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abbas road</term>
<term>Adequate steps</term>
<term>Affordable</term>
<term>Affordable cost</term>
<term>Affordable prices</term>
<term>Africa aids conference</term>
<term>Africa aids fight</term>
<term>Africa fight aids</term>
<term>African countries</term>
<term>African government</term>
<term>African health minister</term>
<term>African judge edwin cameron</term>
<term>Aids anand kumar</term>
<term>Aids apathy</term>
<term>Aids crisis</term>
<term>Aids drugs</term>
<term>Anand kumar hope infertility clinic</term>
<term>Asian wall street journal</term>
<term>Associate professor</term>
<term>Average time</term>
<term>Bombay university</term>
<term>Capita expenditure</term>
<term>Catastrophic situation</term>
<term>Causative agent</term>
<term>Cheap drugs</term>
<term>Cheaper versions</term>
<term>Civilized societies</term>
<term>Clinical trials</term>
<term>Commercial opportunity</term>
<term>Companies charge</term>
<term>Competitive prices</term>
<term>Compulsory licensing</term>
<term>Costly treatment</term>
<term>Countries india</term>
<term>Countries need</term>
<term>Countries need drugs</term>
<term>Court action</term>
<term>Current approach</term>
<term>Current price</term>
<term>Demographic characteristics</term>
<term>Drug companies</term>
<term>Drug companies sound</term>
<term>Drugs patent</term>
<term>Durban</term>
<term>Durban conference</term>
<term>Durban meeting</term>
<term>Dynamic leadership</term>
<term>Epidemiological proportions</term>
<term>Exclusive basis</term>
<term>Expensive drugs</term>
<term>Free importation</term>
<term>Gatt</term>
<term>Gatt treaty</term>
<term>General agreement</term>
<term>Generic drugs</term>
<term>Generic forms</term>
<term>Generic sources</term>
<term>Glaxo smith kline</term>
<term>Global attention</term>
<term>Global scale</term>
<term>Good intentions</term>
<term>Heavy investments</term>
<term>High cost</term>
<term>High quality</term>
<term>Hope infertiltiy clinic</term>
<term>Human disease</term>
<term>Human immunodeficiency virus</term>
<term>Humane response</term>
<term>Icmr institute</term>
<term>India institute</term>
<term>Intellectual property laws</term>
<term>Intellectual property rights</term>
<term>Journal middle</term>
<term>Kumar agreement</term>
<term>Lancet</term>
<term>Legal action</term>
<term>Legal method</term>
<term>Legitimate steps</term>
<term>Long time</term>
<term>Lower birth rates</term>
<term>Manufacturers association</term>
<term>Manufacturing capabilities</term>
<term>Many books</term>
<term>Medical problem</term>
<term>Medical sciences</term>
<term>Moral pressure</term>
<term>More leeway</term>
<term>National institutes</term>
<term>News item</term>
<term>News items</term>
<term>Nonexclusive basis</term>
<term>Nucleoside analogue</term>
<term>Older people</term>
<term>Patent infringement</term>
<term>Patent laws</term>
<term>Patent protection</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical aids</term>
<term>Pharmaceutical companies</term>
<term>Policy change</term>
<term>Poor countries</term>
<term>Poor people</term>
<term>Poorer nations</term>
<term>Preventable deaths</term>
<term>Price controls</term>
<term>Price variations</term>
<term>Protease inhibitors</term>
<term>Public hospitals</term>
<term>Public laboratories</term>
<term>Public research institutes</term>
<term>Public research institutions</term>
<term>Rajasthan university</term>
<term>Recent price comparison</term>
<term>Recent report</term>
<term>References asian wall street journal</term>
<term>Reproductive biology</term>
<term>Reproductive biomedicine</term>
<term>Reproductive endocrinology</term>
<term>Retrospective commentaries</term>
<term>Rich country</term>
<term>Similar manufacturing capabilities</term>
<term>Societal disruption</term>
<term>Stark warning</term>
<term>Such arguments</term>
<term>Such inequities</term>
<term>Supply drugs</term>
<term>Third world</term>
<term>Triple therapy</term>
<term>Unblocks drugs</term>
<term>World health organization</term>
<term>World news service</term>
<term>World service</term>
<term>World service report</term>
<term>World trade organisation</term>
<term>Younger adults</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Action en justice</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Inde</li>
</country>
</list>
<tree><country name="Inde"><noRegion><name sortKey="Kumar, Anand" sort="Kumar, Anand" uniqKey="Kumar A" first="Anand" last="Kumar">Anand Kumar</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001091 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001091 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaGhanaV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:42F16BF47161A6DDF7518785277F45A90B716F0F |texte= Developing countries need drugs at affordable cost for prevention of AIDS }}
This area was generated with Dilib version V0.6.31. |